Novonesis A/s Class B · OMXCOP:NSIS_B

Novonesis A/s Class B — Novozymes — 9M 2017 Earnings Presentation

11 slides from Novonesis A/s Class B's earnings presentation, Oct 25, 2017

  1. Slide 1: Novozymes Conference Call 9M 2017

    Novozymes Conference Call 9M 2017 October 25, 2017

  2. Slide 2: Continued good momentum

    9M 2017 Continued good momentum 9M y/y organic sales growth per segment Highlights • Organic sales growth +4% (Q3: +8%) • Large segments growing organically: 9% 10% ‒ Household Care +2% (Q3: +4%) ‒ Food & Beverages +9% (Q3: +11%) ‒ Bioenergy +10% (Q3: +16%) 2% • Improving relative to after first-hal

  3. Slide 3: Organic sales growth by geography

    Organic sales growth by geography +5% +4% Q3 y/y 9M y/y +6% +4% +12% Q3 y/y 37% +6% Q3 y/y 9M y/y of sales 9M y/y 33% 20% of sales of sales +10% +3% Q3 y/y 9M y/y 10% of sales 9M y/y organic sales growth Emerging markets: +4% (Q3 y/y +9%) Developed markets:+4% (Q3 y/y +8%) 3

  4. Slide 4: Household Care

    Household Care First nine months in line with expectations 9M y/y organic sales growth • Organic growth y/y: 9M +2%. Q3 +4% • Growth in both developed and emerging markets 33% of sales • Enzyme technology for liquid formulations supporting growth in Asia Pacific, in particular China 8% • Top-20 cust

  5. Slide 5: Food & Beverages

    Food & Beverages Solid performance also nine months into the year 9M y/y organic sales growth • Organic growth y/y: 9M +9%. Q3 +11% • Nutrition continues good momentum, driven by both lactose 28% reduction in dairy and infant nutrition 9% of sales • Starch continues strong performance, driven mainly

  6. Slide 6: Bioenergy

    Bioenergy Solid growth in enzymes for conventional biofuels 9M y/y organic sales growth • Organic growth y/y: 9M +10%. Q3 +16% 18% • US ethanol production estimated to be up ~2% in first 9M y/y 23% of sales (Q3 y/y estimated flat). US ethanol inventories remain elevated • Growth in conventional biof

  7. Slide 7: Agriculture & Feed

    Agriculture & Feed Growth picking up after -6% in 1H y/y 9M y/y organic sales growth • Organic growth y/y: 9M -2%. Q3 +8% 14% • Sales increased due to expected sales cycle change in Agriculture of sales from first to second half of the year 19% • Feed enzymes sales lower in Q3 due to volatile invent

  8. Slide 8: Innovation and science-based culture

    Innovation and science-based culture Hello Acceleron® Progress® Science Freshness and Medley® B-200 SAT Excel Hygiene (Q4e) 2017 Q1 Q2 Q3 Q4 ”World’s 2nd best science employer” Spirizyme® T Palmora® Frontia® Progress® In according to Science Magazine 8

  9. Slide 9: 9M performance and 2017 outlook

    9M performance and 2017 outlook 9M 2017: Continued good momentum, better than expected Key financials Realized 2017 outlook • Continued growth in the large segments: Household Care, (DKKm) 9M 2017 October 25 Food & Beverages, Bioenergy Organic sales growth +4% 3-5% • Agriculture & Feed improving • E

  10. Slide 10: Forward-looking statements

    Forward-looking statements This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limited to, "bel

  11. Slide 11: Q&A

    Q&A • Continued good momentum, better than expected • Full-year outlook adjusted after better-than-expected 9M performance • Stronger connection between application R&D and commercial organization enables more impactful innovation • Our business is about turning amazing science into sustainable biol

Novozymes — 9M 2017 Earnings Presentation on 6ix